PAI-1 在II型膜上皮细胞中调节p53表达和衰老
Tapasi Rana1, Chunsun Jiang1, Sami Banerjee1
1Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
血原激活剂抑制剂1 (PAI-1) 通过抑制蛋白酶体活性和肺细胞中的p53降解来促进细胞衰老. 这一发现影响了对衰老,肺纤维化和其他与衰老相关的疾病的理解.
科学领域:
- 细胞和分子生物学 细胞和分子生物学
- 衰老研究研究 衰老研究
- 肺部医学 肺部医学
背景情况:
- 细胞衰老是衰老和诸如异常性肺纤维化 (IPF) 等疾病的关键因素.
- 在IPF中观察到膜上皮类型II (ATII) 细胞的衰老.
- 之前的工作通过p53通路将等离子体激活剂抑制剂1 (PAI-1) 与ATII细胞衰老联系起来.
研究的目的:
- 研究PAI-1诱导ATII细胞衰老的机制.
- 为了确定PAI-1是否与蛋白质酶相互作用以影响p53降解.
主要方法:
- 评估肺上皮细胞 (A549) 和小鼠ATII细胞中的蛋白酶体活性和p53降解.
- 分析衰老标志物,包括p53,p21,pRb酸化和SA-β-gal活性.
- 比较野生型PAI-1 (wtPAI-1) 和分泌不足PAI-1 (sdPAI-1) 的影响.
主要成果:
- PAI-1 结合了蛋白质酶组件,抑制了蛋白质酶活性和p53降解.
- 这种抑制导致p53和p21表达增加,pRb酸化降低,SA-β-gal活性升高,表明衰老.
- 只有wtPAI-1,而不是sdPAI-1,诱导了p53,这表明PAI-1的过早形式是蛋白质酶相互作用所必需的.
结论:
- PAI-1 直接抑制ATII细胞中的蛋白酶体活性和p53降解.
- 这种机制有助于ATII细胞衰老,可能与IPF和其他与衰老相关的疾病有关.
- 这些发现提供了针对PAI-1治疗治疗老化和纤维化疾病的治疗干预措施的见解.
更多相关视频
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
08:18Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
相关概念视频
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Replicative Cell Senescence
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
